546 results on '"Altun, Zekiye"'
Search Results
2. Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
3. Investigation of YAP‐1, OTX‐2, and nestin protein expressions in neuroblastoma: a preliminary study.
4. Assessment of Ferroptotic Cell Death and Related Treatment Targets in Neuroblastoma.
5. The Impact of Oleuropein on Cisplatin-Induced Toxicity in Cochlear Cells in Relation to the Expression of Deoxyribonucleic Acid Damage-Associated Genes.
6. Genomic Alterations of Signaling and DNA Damage Repair Pathways in Non-muscle Invasive Bladder Cancer
7. S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients
8. Experimental Peritoneal Metastasis Model: Which Type of Rodents Should we Choose, and which Method Should we Perform for the Intraperitoneal Inoculation of Tumor Cells?
9. Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies
10. Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance
11. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma
12. Investigation of The Effectıveness of Hyperthermic Intraperitoneal Chemotherapy in Experimental Colorectal Peritoneal Metastasis Model
13. N-Nitro-L-Arginine Methyl Ester Hydrochloride Induced Endothelial Dysfunction and Atherosclerosis Model in Rats
14. Anna Karenina principle in personalized treatment of bladder cancer according to oncogram: which drug for which patient?
15. Which Mechanism is Effective on the Hyperamylasaemia After Coronary Artery Bypass Surgery?
16. S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients.
17. COMPARISON OF EFFICACY OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPEUTICS MITOMYCIN C VERSUS OXALIPLATIN IN EXPERIMENTAL COLORECTAL PERITONEAL METASTASIS MODEL.
18. Dexamethasone Addition Impairs the Therapeutic Effects of Nimodipine for Subarachnoid Hemorrhage: An Experimental Animal Study.
19. Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity.
20. Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients
21. Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients
22. The effects of boric acid and disodium pentaborate dechydrate in metastatic prostate cancer cells
23. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma
24. Noroblastomda Molekuler Heterojenite Ve Klinik Onemi - Molecular Heterogeneity In Neuroblastoma And Its Clinical Significance
25. Nöroblastomda Retinoik Aside Bağlı Diferansiasyon ve Eksozom Aracılı miRNA Ekspresyonları (TPOG Adına)
26. Sisplatin ototoksisitesinde gen değişimi düzeyinde yeni biyobelirteç geliştirme (TPOG ADINA)
27. IMMUNE AND INFLAMATORYRESPONSE HETEROGENEITY IN NEUROBLASTOMA Nöroblastomda immun ve inflamatuar cevapta heterojenite
28. IMMUNE AND INFLAMATORYRESPONSE HETEROGENEITY IN NEUROBLASTOMA
29. Differences in the Differential Expression of MicroRNAs Between Patients with Familial Multiple Sclerosis and Those with Sporadic Multiple Sclerosis.
30. Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients.
31. More Abundant Superoxide Dismutase2 Protein Levels in Blood May Act as a Prognostic Marker for High-Risk Neuroblastoma Patients
32. SİSPLATİNE BAĞLI OTOTOKSİSİTEDE DARBEPOETİNİN KORUYUCU ROLÜ
33. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma
34. Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
35. Review of: "Scintigraphic and histopathologic evaluation of the protective effect of L-carnitine on the development of radiation-induced kidney damage in infant rats"
36. SİSPLATİNE BAĞLI OTOTOKSİSİTEDE DARBEPOETİNİN KORUYUCU ROLÜ
37. RNA-Sequencing Technologies for Gaining New Insights About Pediatric Cancers
38. Evaluation of Yap-1 in Risk Classes and Prognosis in Neuroblastoma
39. Evaluation of MicroRNA Expressions in Ovarian Cancer
40. Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
41. Protective role of Darbopoetin in Cisplatin-Induced Ototoxicity
42. İDİYOPATİK NORMAL BASINÇLI HİDROSEFALİ VE NÖRODEJENERATİF DEMANSLARDA BEYİN OMURİLİK SIVISI BETA-AMİLOİD VE TAU'NUN KARŞILAŞTIRILMASI
43. Pediatrik Burkitt lenfomalarda miRNA-seq ile belirlenen miRNA seviyelerinin non-invazif tanı biyobelirteç potansiyelleri
44. INTEGRATIVE ANALYSIS OF FEN1 EXPRESSION AND PROGNOSTIC IMPACT IN NEUROBLASTOMA
45. DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS
46. Hastalıkta ve Sağlıkta Hücre Ölümü- Mekanizmaları ve Deneysel Araştırma Modelleri
47. Comparison of Cytotoxic and Ototoxic Effects of Lipoplatin and Cisplatin in Neuroblastoma In Vivo Tumor Model
48. EFFECT OF THYMOQUINONE IN COMBINATION WITH NIVOLUMAB ON EXPERIMENTAL RENAL CELL CANCER MODELS
49. Hastalıkta ve Sağlıkta Hücre Ölümü- Mekanizmaları ve Deneysel Araştırma Modelleri
50. Hastalıkta ve Sağlıkta Hücre Ölümü- Mekanizmaları ve Deneysel Araştırma Modelleri
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.